Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 198

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production

Guidetti, Paolo, Charles, Vinod, Chen, Er-Yun, Reddy, P.Hemachandra, Kordower, Jeffrey H., Whetsell, William O., Schwarcz, Robert, Tagle, Danilo A.·2001·Experimental Neurology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1006/exnr.2000.7626

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 67

  1. Ackrell, 1978, Mammalian succinate dehydrogenase, Methods Enzymol., 53, 466, 10.1016/S0076-6879(78)53050-4 · DOI · Paper page
  2. Alexi, 1998, Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague–Dawley rats but not in BALB/c ByJ mice, Exp. Neurol., 153, 74, 10.1006/exnr.1998.6842 · DOI
  3. Andrade, 1995, HEAT repeats in the Huntington's disease protein, Nat. Genet., 11, 115, 10.1038/ng1095-115 · DOI · Paper page
  4. Antonini, 1996, Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease, Brain, 119, 2085, 10.1093/brain/119.6.2085 · DOI · Paper page
  5. Arenas, 1998, Complex I defect in muscle from patients with Huntington's disease, Ann. Neurol., 43, 397, 10.1002/ana.410430321 · DOI · Paper page
  6. Aronin, 1999, Are there multiple pathways in the pathogenesis of Huntington's disease?, Philos. Trans. R. Soc. London B, 354, 995, 10.1098/rstb.1999.0451 · DOI
  7. Beal, 1993, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci., 16, 125, 10.1016/0166-2236(93)90117-5 · DOI · Paper page
  8. Beal, 1998, Mitochondrial dysfunction in neurodegenerative diseases, Biochim. Biophys. Acta, 1366, 211, 10.1016/S0005-2728(98)00114-5 · DOI · Paper page
  9. Beal, 1993, Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid, J. Neurosci., 13, 4181, 10.1523/JNEUROSCI.13-10-04181.1993 · DOI · Paper page
  10. Beal, 1993, Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate, J. Neurochem., 61, 1147, 10.1111/j.1471-4159.1993.tb03633.x · DOI · Paper page
  11. Berent, 1988, Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function, Ann. Neurol., 23, 541, 10.1002/ana.410230603 · DOI · Paper page
  12. Bernard, 1998, Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: Co-localization at synapses with the GluR2/3 subunit of the AMPA receptor, Eur. J. Neurosci., 10, 3721, 10.1046/j.1460-9568.1998.00380.x · DOI
  13. Bowling, 1995, Bioenergetic and oxidative stress in neurodegenerative diseases, Life Sci., 56, 1151, 10.1016/0024-3205(95)00055-B · DOI · Paper page
  14. Brennan, 1985, Regional mitochondrial respiratory activity in Huntington's disease brain, J. Neurochem., 44, 1948, 10.1111/j.1471-4159.1985.tb07192.x · DOI · Paper page
  15. Burke, 1996, Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH, Nat. Med., 2, 347, 10.1038/nm0396-347 · DOI · Paper page
  16. Ferrante, 1991, Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: A combined study using the section-Golgi method and calbindin D28k immunocytochemistry, J. Neurosci., 11, 3877, 10.1523/JNEUROSCI.11-12-03877.1991 · DOI · Paper page
  17. Gonzalez-Lima, 1991, Quantitative histochemistry of cytochrome oxidase in rat brain, Neurosci. Lett., 123, 251, 10.1016/0304-3940(91)90943-N · DOI
  18. Grafton, 1990, A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease, Ann. Neurol., 28, 614, 10.1002/ana.410280503 · DOI
  19. Grafton, 1992, Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease, Arch. Neurol., 49, 1161, 10.1001/archneur.1992.00530350075022 · DOI · Paper page
  20. Graveland, 1985, Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease, Science, 227, 770, 10.1126/science.3155875 · DOI · Paper page
  21. Greene, 1995, Exacerbation of NMDA, AMPA, and l-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate, J. Neurochem., 64, 2332, 10.1046/j.1471-4159.1995.64052332.x · DOI
  22. Greene, 1996, Bioenergetics and glutamate excitotoxicity, Prog. Neurobiol., 48, 613, 10.1016/0301-0082(96)00006-8 · DOI · Paper page
  23. Gutekunst, 1998, The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human, J. Neurosci., 18, 7674, 10.1523/JNEUROSCI.18-19-07674.1998 · DOI · Paper page
  24. Halkjaer-Kristensen, 1979, Microphotometric analysis of NADH-tetrazolium reductase and alpha-glycerophosphate dehydrogenase in human quadriceps muscle, Histochem. J., 11, 127, 10.1007/BF01002990 · DOI
  25. Harris, 1999, Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease, Brain, 122, 1667, 10.1093/brain/122.9.1667 · DOI
  26. Hatefi, 1978, Preparation and properties of dihydroubiquinone: cytochrome c oxidoreductase (complex III), Methods Enzymol., 53, 35, 10.1016/S0076-6879(78)53010-3 · DOI
  27. Hatefi, 1978, Preparation and properties of NADH: Ubiquinone oxidoreductase (complex I), EC 1.6.5.3, Methods Enzymol., 53, 11, 10.1016/S0076-6879(78)53006-1 · DOI · Paper page
  28. Hess, 1953, Ultramicrospectrophotomeric determination of cytochrome oxidase for quantitative histochemistry, J. Biol. Chem., 204, 296, 10.1016/S0021-9258(18)66139-3 · doi:10.1016/s0021-9258(18)66139-3
  29. Hyrc, 1997, Ionized intracellular calcium concentration predicts excitotoxic neuronal death: Observations with low-affinity fluorescenct calcium indicators, J. Neurosci., 17, 6669, 10.1523/JNEUROSCI.17-17-06669.1997 · DOI · Paper page
  30. Izumi, 1997, Endogenous monocarboxylates sustain hippocampal synaptic function and morphological integrity during energy deprivation, J. Neurosci., 17, 9448, 10.1523/JNEUROSCI.17-24-09448.1997 · DOI · Paper page
  31. Jenkins, 1996, Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging, J. Cereb. Blood Flow Metab., 16, 450, 10.1097/00004647-199605000-00011 · DOI
  32. Jenkins, 1993, Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy, Neurology, 43, 2689, 10.1212/WNL.43.12.2689 · DOI · Paper page
  33. Jenkins, 1998, 1H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers, Neurology, 50, 1357, 10.1212/WNL.50.5.1357 · DOI · Paper page
  34. Kieburtz, 1999, Antiglutamate therapies in Huntington's disease, J. Neural Transm. Suppl., 55, 97
  35. Klivenyi, 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, Nat. Med., 5, 347, 10.1038/6568 · DOI · Paper page
  36. Kuppenbender, 2000, Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum, J. Comp. Neurol., 419, 407, 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I · DOI
  37. Landas, 1982, Staining of human and rat brain Vibratome sections by a new Golgi method, J. Neurosci. Methods, 5, 147, 10.1016/0165-0270(82)90061-9 · doi:10.1016/0165-0270(82)90061-9
  38. Li, 1993, Huntington's disease gene (IT15) is widely expressed in human and rat tissues, Neuron, 11, 985, 10.1016/0896-6273(93)90127-D · DOI · Paper page
  39. Li, 1995, A huntingtin-associated protein enriched in brain with implications for pathology, Nature, 378, 398, 10.1038/378398a0 · DOI · Paper page
  40. Lipton, 1991, Calcium channel antagonists in the prevention of neurotoxicity, Adv. Pharmacol., 22, 271, 10.1016/S1054-3589(08)60038-1 · DOI
  41. Maus, 1999, Pyruvate and lactate protect striatal neurons against N-methyl-D-aspartate-induced neurotoxicity, Eur. J. Neurosci., 11, 3215, 10.1046/j.1460-9568.1999.00745.x · DOI
  42. Mazziotta, 1987, Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease, N. Engl. J. Med., 316, 357, 10.1056/NEJM198702123160701 · DOI · Paper page
  43. Ona, 1999, Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease, Nature, 399, 263, 10.1038/20446 · DOI · Paper page
  44. Page, 1998, The expression of Huntingtin-associated protein (HAP1) mRNA in developing, adult and ageing rat CNS: Implications for Huntington's disease neuropathology, Eur. J. Neurosci., 10, 1835, 10.1046/j.1460-9568.1998.00185.x · DOI
  45. Parker, 1990, Evidence for a defect in NADH: Ubiquinone oxidoreductase (complex I) in Huntington's disease, Neurology, 40, 1231, 10.1212/WNL.40.8.1231 · DOI · Paper page
  46. Patel, 1996, Requirement for superoxide in excitotoxic cell death, Neuron, 16, 345, 10.1016/S0896-6273(00)80052-5 · DOI · Paper page
  47. Poeggeler, 1998, Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum, Dev. Neurosci., 20, 146, 10.1159/000017309 · DOI
  48. Reddy, 1999, Transgenic mice expressing mutated full-length HD cDNA: A paradigm for locomotor changes and selective neuronal loss in Huntington's disease, Philos Trans. R. Soc. London B, 354, 1035, 10.1098/rstb.1999.0456 · DOI
  49. Reddy, 1998, Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA, Nat. Genet., 20, 198, 10.1038/2510 · DOI · Paper page
  50. Reddy, 1999, Recent advances in understanding the pathogenesis of Huntington's disease, Trends Neurosci., 22, 248, 10.1016/S0166-2236(99)01415-0 · DOI · Paper page
  51. Sanchez-Pernaute, 1999, Clinical correlation of striatal 1H MRS changes in Huntington's disease, Neurology, 53, 806, 10.1212/WNL.53.4.806 · DOI
  52. Sawa, 1999, Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization, Nat. Med., 5, 1194, 10.1038/13518 · DOI · Paper page
  53. Schapira, 1998, Mitochondrial dysfunction in neurodegenerative disorders, Biochim. Biophys. Acta, 1366, 225, 10.1016/S0005-2728(98)00115-7 · DOI · Paper page
  54. Schurr, 1999, An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons, J. Neurosci., 19, 34, 10.1523/JNEUROSCI.19-01-00034.1999 · DOI · Paper page
  55. Schurr, 1997, Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia, Brain Res., 4, 221, 10.1016/S0006-8993(97)81708-8 · DOI
  56. Schwarcz, 1983, Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain, Science, 219, 316, 10.1126/science.6849138 · DOI · Paper page
  57. Sharp, 1995, Widespread expression of Huntington's disease gene (IT15) protein product, Neuron, 14, 1065, 10.1016/0896-6273(95)90345-3 · DOI · Paper page
  58. Soltanpour, 1996, Neurons and microvessels of the nodose (vagal sensory) ganglion in young adult and aged rats: Morphometric and enzyme histochemical studies, Tissue Cell, 28, 593, 10.1016/S0040-8166(96)80062-0 · doi:10.1016/s0040-8166(96)80062-0
  59. Strong, 1993, Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues, Nat. Genet., 5, 259, 10.1038/ng1193-259 · DOI · Paper page
  60. Tabrizi, 1999, Biochemical abnormalities and excitotoxicity in Huntington's disease brain, Ann. Neurol., 45, 25, 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E · doi:10.1002/1531-8249(199901)45:1<25::aid-art6>3.0.co;2-e
  61. Tabrizi, 2000, Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse, Ann. Neurol., 47, 80, 10.1002/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K · DOI · Paper page
  62. Tsacopoulos, 1996, Metabolic coupling between glia and neurons, Neurosci. Lett., 16, 877
  63. Valdes, 1993, A simple non-radioactive method for diagnosis of Huntington's disease, Hum. Mol. Genet., 2, 633, 10.1093/hmg/2.6.633 · DOI
  64. Vonsattel, 1985, Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol., 44, 559, 10.1097/00005072-198511000-00003 · DOI · Paper page
  65. Wong-Riley, 1989, Cytochrome oxidase: an endogenous metabolic marker for neuronal activity, Trends Neurosci., 12, 94, 10.1016/0166-2236(89)90165-3 · DOI · Paper page
  66. Zeevalk, 1991, Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition, J. Pharmacol. Exp. Ther., 257, 870
  67. Zeevalk, 1993, Hypothermia, metabolic stress, and NMDA-mediated excitotoxicity, J. Neurochem., 61, 1153, 10.1111/j.1471-4159.1993.tb13639.x · doi:10.1111/j.1471-4159.1993.tb13639.x

Cited by

See all 198

Metadata

Authors
Guidetti, P., Charles, V., Chen, E.-Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R., & Tagle, D. A.
Venue
Experimental Neurology
Publisher
Elsevier BV
Published
2001-06
Volume
169
Issue
2
Pages
340-350
ISSN
0014-4886 (ISSN-L)
OpenAlex
W2022863516
Cited by
198
References
8
FWCI
4.52
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production. https://app.cochat.ai/papers/10.1006/exnr.2000.7626
The paper
Guidetti, P., Charles, V., Chen, E.-Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R., & Tagle, D. A. (2001). Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production. Experimental Neurology. https://doi.org/10.1006/exnr.2000.7626

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.